Archives for October 21, 2008

← 2008

Big pharma Q3 results = big smiles?

By Nick Taylor

Pfizer and Schering-Plough have both exceeded their earnings estimates, although this was largely underpinned by favourable exchange rates and low expectations.

Ethex recalls its second oversized drug this year

By Gareth Macdonald

Ethex has withdrawn three lots of its generic drug dextroamphetamine sulphate, which is used to treat ADHD and narcolepsy, after analysis revealed that some oversized tablets had been produced.

3M and Vaxlnnate pal up for pandemic patch

By Gareth Macdonald

3M’s drug delivery division and US biotechnology firm VaxInnate have teamed up to develop transdermal influenza vaccine delivery patch in preparation for the anticipated pandemic.

Eisai plans to open Indian API plant by 2011

By Gareth Macdonald

India’s reputation as a base for quality, low-cost drug manufacture has proved irresistible for yet another big pharma company with Japan’s Eisai unveiling plans for a new production and R&D facility.

Drug delivery tech receives funding

By Nick Taylor

NovaDel Pharma has secured $2.5m in financing, some of which will be used to further use of its proprietary drug delivery technology.